ask="3.06"
ask_size="2000"
average_daily_volume="4152510"
bid="3.01"
bid_size="1000"
book_value="-1.75"
change="-0.18"
change_from_200_day_moving_average="-2.09"
change_from_50_day_moving_average="-1.12"
change_from_52_week_high="-6.00"
change_From_52_week_low="0.19"
change_in_percent="-5.63%"
close="3.02"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.37"
ebitda="-120.56M"
eps_estimate_current_year="-1.16"
eps_estimate_next_quarter="-0.10"
eps_estimate_next_year="-0.23"
ex_dividend_date="N/A"
float_shares="122562000"
high="3.24"
high_52_weeks="9.02"
last_trade_date="1/26/2017"
last_trade_price="3.02"
last_trade_size="46733"
last_trade_time="4:00pm"
low="3.01"
low_52_weeks="2.83"
market_capitalization="391.44M"
moving_average_200_day="5.11"
moving_average_50_day="4.14"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.00"
open="3.22"
pe_ratio="N/A"
peg_ratio="-0.46"
percent_change_from_200_day_moving_average="-40.87%"
percent_change_from_50_day_moving_average="-27.05%"
percent_change_from_52_week_high="-66.50%"
percent_change_from_52_week_low="+6.71%"
previous_close="3.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="3.97"
revenue="104.45M"
shares_outstanding="129615000"
short_ratio="14.12"
stock_exchange="NGM"
symbol="MACK"
volume="2234284"
weeks_range_52="2.83 - 9.02"
